Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis.

<h4>Background</h4>The aim of this study was to estimate the economic burden of diabetes mellitus (DM) in Iran from 2009 to 2030.<h4>Methods</h4>A Markov micro-simulation (MM) model was developed to predict the DM population size and associated economic burden. Age- and sex-s...

Full description

Saved in:
Bibliographic Details
Main Authors: Mehdi Javanbakht, Atefeh Mashayekhi, Hamid R Baradaran, AliAkbar Haghdoost, Ashkan Afshin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0132505&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849726786360836096
author Mehdi Javanbakht
Atefeh Mashayekhi
Hamid R Baradaran
AliAkbar Haghdoost
Ashkan Afshin
author_facet Mehdi Javanbakht
Atefeh Mashayekhi
Hamid R Baradaran
AliAkbar Haghdoost
Ashkan Afshin
author_sort Mehdi Javanbakht
collection DOAJ
description <h4>Background</h4>The aim of this study was to estimate the economic burden of diabetes mellitus (DM) in Iran from 2009 to 2030.<h4>Methods</h4>A Markov micro-simulation (MM) model was developed to predict the DM population size and associated economic burden. Age- and sex-specific prevalence and incidence of diagnosed and undiagnosed DM were derived from national health surveys. A systematic review was performed to identify the cost of diabetes in Iran and the mean annual direct and indirect costs of patients with DM were estimated using a random-effect Bayesian meta-analysis. Face, internal, cross and predictive validity of the MM model were assessed by consulting an expert group, performing sensitivity analysis (SA) and comparing model results with published literature and national survey reports. Sensitivity analysis was also performed to explore the effect of uncertainty in the model.<h4>Results</h4>We estimated 3.78 million cases of DM (2.74 million diagnosed and 1.04 million undiagnosed) in Iran in 2009. This number is expected to rise to 9.24 million cases (6.73 million diagnosed and 2.50 million undiagnosed) by 2030. The mean annual direct and indirect costs of patients with DM in 2009 were US$ 556 (posterior standard deviation, 221) and US$ 689 (619), respectively. Total estimated annual cost of DM was $3.64 (2009 US$) billion (including US$1.71 billion direct and US$1.93 billion indirect costs) in 2009 and is predicted to increase to $9.0 (in 2009 US$) billion (including US$4.2 billion direct and US$4.8 billion indirect costs) by 2030.<h4>Conclusions</h4>The economic burden of DM in Iran is predicted to increase markedly in the coming decades. Identification and implementation of effective strategies to prevent and manage DM should be considered as a public health priority.
format Article
id doaj-art-bbf97fe67e2e479f9df2fe881a0a45dc
institution DOAJ
issn 1932-6203
language English
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-bbf97fe67e2e479f9df2fe881a0a45dc2025-08-20T03:10:05ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01107e013250510.1371/journal.pone.0132505Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis.Mehdi JavanbakhtAtefeh MashayekhiHamid R BaradaranAliAkbar HaghdoostAshkan Afshin<h4>Background</h4>The aim of this study was to estimate the economic burden of diabetes mellitus (DM) in Iran from 2009 to 2030.<h4>Methods</h4>A Markov micro-simulation (MM) model was developed to predict the DM population size and associated economic burden. Age- and sex-specific prevalence and incidence of diagnosed and undiagnosed DM were derived from national health surveys. A systematic review was performed to identify the cost of diabetes in Iran and the mean annual direct and indirect costs of patients with DM were estimated using a random-effect Bayesian meta-analysis. Face, internal, cross and predictive validity of the MM model were assessed by consulting an expert group, performing sensitivity analysis (SA) and comparing model results with published literature and national survey reports. Sensitivity analysis was also performed to explore the effect of uncertainty in the model.<h4>Results</h4>We estimated 3.78 million cases of DM (2.74 million diagnosed and 1.04 million undiagnosed) in Iran in 2009. This number is expected to rise to 9.24 million cases (6.73 million diagnosed and 2.50 million undiagnosed) by 2030. The mean annual direct and indirect costs of patients with DM in 2009 were US$ 556 (posterior standard deviation, 221) and US$ 689 (619), respectively. Total estimated annual cost of DM was $3.64 (2009 US$) billion (including US$1.71 billion direct and US$1.93 billion indirect costs) in 2009 and is predicted to increase to $9.0 (in 2009 US$) billion (including US$4.2 billion direct and US$4.8 billion indirect costs) by 2030.<h4>Conclusions</h4>The economic burden of DM in Iran is predicted to increase markedly in the coming decades. Identification and implementation of effective strategies to prevent and manage DM should be considered as a public health priority.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0132505&type=printable
spellingShingle Mehdi Javanbakht
Atefeh Mashayekhi
Hamid R Baradaran
AliAkbar Haghdoost
Ashkan Afshin
Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis.
PLoS ONE
title Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis.
title_full Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis.
title_fullStr Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis.
title_full_unstemmed Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis.
title_short Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis.
title_sort projection of diabetes population size and associated economic burden through 2030 in iran evidence from micro simulation markov model and bayesian meta analysis
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0132505&type=printable
work_keys_str_mv AT mehdijavanbakht projectionofdiabetespopulationsizeandassociatedeconomicburdenthrough2030iniranevidencefrommicrosimulationmarkovmodelandbayesianmetaanalysis
AT atefehmashayekhi projectionofdiabetespopulationsizeandassociatedeconomicburdenthrough2030iniranevidencefrommicrosimulationmarkovmodelandbayesianmetaanalysis
AT hamidrbaradaran projectionofdiabetespopulationsizeandassociatedeconomicburdenthrough2030iniranevidencefrommicrosimulationmarkovmodelandbayesianmetaanalysis
AT aliakbarhaghdoost projectionofdiabetespopulationsizeandassociatedeconomicburdenthrough2030iniranevidencefrommicrosimulationmarkovmodelandbayesianmetaanalysis
AT ashkanafshin projectionofdiabetespopulationsizeandassociatedeconomicburdenthrough2030iniranevidencefrommicrosimulationmarkovmodelandbayesianmetaanalysis